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Ordered assembly of roX RNAs into MSL complexes on the
dosage-compensated X chromosome in Drosophila
V.H. Meller*†, P.R. Gordadze‡, Y. Park*, X. Chu‡, C. Stuckenholz§, R.L. Kelley*
and M.I. Kuroda*‡§
Background: In the male Drosophila, the X chromosome is transcriptionally
upregulated to achieve dosage compensation, in a process that depends on
association of the MSL proteins with the X chromosome. A role for
non-coding RNAs has been suggested in recent studies. The roX1 and roX2
RNAs are male-specific, non-coding RNAs that are produced by, and also
found associated with, the dosage-compensated male X chromosome.
Whether roX RNAs are physically part of the MSL complex has not
been resolved. 
Results: We found that roX RNAs colocalize with the MSL proteins and are
highly unstable unless the MSL complex is coexpressed, suggesting a physical
interaction. We were able to immunoprecipitate roX2 RNA from male
tissue-culture cells with antibodies to the proteins Msl1 and Mle, consistent
with an integral association with MSL complexes. Localization of roX1 and roX2
RNAs in mutants indicated an order of MSL-complex assembly in which roX2
RNA is incorporated early in a process requiring the Mle helicase. We also
found that the roX2 gene, like roX1, is a nucleation site for MSL complex
spreading into flanking chromatin in cis. 
Conclusions: Our results support a model in which MSL proteins assemble at
specific chromatin entry sites (including the roX1 and roX2 genes); the roX
RNAs join the complex at their sites of synthesis; and complete complexes
spread in cis to dosage compensate most genes on the X chromosome. 
Background
The process of dosage compensation equalizes the
amount of products encoded by X-linked genes in males
(XY or XO) and females (XX). Mammals, flies and nema-
todes have evolved dramatically different mechanisms to
cope with chromosomal differences between the sexes
(reviewed in [1–3]). A unifying theme, however, is that
remodeling chromatin architecture is likely to play a major
role in each case. Two distinct mechanisms of dosage com-
pensation have been postulated to operate in Drosophila
(reviewed in [4]). In the predominant pathway, five known
proteins are thought to assemble into a large complex,
which binds to hundreds of sites along the male X chromo-
some (reviewed in [3]). These are collectively called the
MSL proteins for their male-specific lethal phenotype
when mutant. An important insight into the molecular
mechanism of the MSL complex has come from the obser-
vation that the male X chromosome is also enriched for a
specific isoform of histone H4 acetylated at Lys16 [5]. This
site-specific histone acetylation is lost if males are mutant
for any of the msl genes [6,7]. A recently discovered MSL
protein, Mof, has sequence similarity to known acetyltrans-
ferases, reinforcing the view that covalent modification of
nucleosomes is a critical function of the MSL complex [7].
Further hints of chromatin modifications come from the
finding that the JIL-1 protein kinase is enriched along the
male X chromosome in a pattern similar to the MSL
complex and displays histone H3 kinase activity in vitro [8].
How the MSL complex specifically recognizes the X
chromosome has been a long-standing question.
Recently, we proposed that Msl1 and Msl2 together rec-
ognize 30–40 chromatin entry sites, distributed along the
length of the X chromosome, where they recruit the
other MSL proteins [9]. Only two chromatin entry sites
have been characterized to date, and they are the genes
that encode roX1 and roX2 (RNA on X) RNAs, which are
male-specific RNAs lacking significant open reading
frames [9–11]. The roX RNAs colocalize with the MSL
proteins along the length of the X chromosome [11,12].
Individually, roX RNAs do not appear essential for MSL
complex assembly on the X chromosome, but assembly
of the complex is delayed or abolished when both RNAs
are removed. This conclusion is based on analysis of
embryos carrying an insertional mutation in roX1 and a
large deletion removing many genes including roX2 [12].
Here, we test the idea that roX RNAs physically associate
with MSL complexes by immunoprecipitation studies,
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and by analyzing roX RNA localization and stability in
the presence and absence of complete MSL complexes. 
We also address the question of how the action of MSL
complexes is normally limited to genes on the X chromo-
some. Recently, we proposed that the 30–40 chromatin
entry sites (including the roX1 and roX2 genes) are not
only assembly sites for MSL complexes but are also nucle-
ation sites for spreading along the chromosome in cis to
dosage-compensate flanking genes, which themselves
may have no X-specific features [9]. The evidence for this
model rests on analysis of the roX1 transgene, which
attracts MSL complexes and roX2 RNA to autosomal
insertion sites, where the complex can spread long dis-
tances into flanking chromatin that was never before
dosage compensated. We perform a critical test of this
model, by determining whether a roX2 transgene can also
establish a nucleation site for MSL spreading into flanking
autosomal chromatin. 
Results
Epigenetic spreading of MSL complexes from a roX2
transgene into flanking chromatin
Wild-type males have complete MSL complexes bound
to hundreds of bands along the X chromosome in a
highly reproducible pattern where they mediate hyper-
transcription. Genetic analysis of debilitated MSL com-
plexes lacking either Mle, Msl3 or Mof subunits, or
containing enzymatically dead Mof acetyltransferase or
Mle helicase, has shown that partial MSL complexes can
bind to only ~35 bands, named chromatin entry sites
(formerly called high-affinity sites [9,13–16]). Recently,
we proposed that these sites direct dosage compensation
to the X chromosome by serving as sites of assembly and
subsequent spreading of the MSL complex into flanking
chromatin in cis [9]. Previously, we identified roX2 as a
chromatin entry site based on the ability of roX2 trans-
genes to attract the MSL complex to autosomal insertion
sites, even in the absence of Msl3. To test whether roX2
could also support spreading of MSL complexes into
flanking autosomes, we created multiple lines of trans-
genic larvae carrying genomic roX2 transgenes. We found
that the roX2 chromatin entry site also supported vari-
able spreading of MSL complexes into flanking chro-
matin (Figure 1). The spreading displayed the same
characteristics as previously reported for a roX1 trans-
gene: bidirectionality, dependence on insertion site, and
substantial variability even from nucleus to nucleus in
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Figure 1
The MSL complex spreads from autosomal roX2 transgenes. (a) The
structure of the roX2 transgene is shown with the P-element ends
indicated by filled circles, the white minigene eye color marker (w+) as
a thick line, and a 4 kb fragment of genomic fly DNA as a thin line. The
direction of roX2 transcription is shown by a black arrow. The 5′ end of
the nod gene lies downstream of roX2. Two different transgenic lines
are shown in (b,c). (b) A polytene chromosome from a [w+ GMroX2-I]
male stained with antibodies to Msl1 (red). DNA is shown in blue. The
MSL complex binds as a sharp band to the autosomal roX2 transgene
at cytological position 67B (arrow). (c) Polytene chromosomes from a
[w+ GMroX2-M] male stained with antibodies to Msl1. The MSL
complex spreads into flanking autosomal chromatin from the transgene
at 95F (arrow), but not the insert at 97F (arrowhead).
Figure 2
Colocalization of roX RNAs and the MSL complex. (a–c) RNA
fluorescence in situ hybridization showing the polytene X
chromosome binding pattern of (a) roX1 RNA and (b) roX2 RNA. A
double exposure showing colocalization of the two non-coding RNAs
is shown in (c). Arrowheads indicate the locations of the roX1 gene
(cytological position 3F) in (a,c), and the roX2 gene (cytological
position 10C) in (b,c). The roX1 RNA typically appears more
concentrated near its site of synthesis. (d–f) Double labeling for
(d) roX1 RNA and (e) MSL-1 (by immunofluorescence) showing
(f) colocalization of roX1 RNA and MSL complexes.
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the same animal. These results strongly support the idea
that most or all chromatin entry sites will act as nucle-
ation points for MSL spreading in cis.
The roX RNAs are dependent on the MSL complex for stability
To determine whether the roX RNAs and MSL proteins
are associated in the same binding pattern on the X chro-
mosome, we adapted the immunostaining protocol to
allow detection of roX RNAs by in situ hybridization to
spread polytene chromosomes. We found that the MSL
proteins, roX1 and roX2 RNAs are precisely colocalized
along the male polytene X chromosome (Figure 2), consis-
tent with previous results based on whole-mount prepara-
tions [11,12]. In addition, we consistently detected a
subtle enrichment for roX1 RNA in several bands sur-
rounding its site of synthesis (Figure 2a,c, arrowhead at
cytological position 3F).
In previous work, MSL proteins were found at decreased
levels when they were unable to assemble into a wild-
type complex [13,17,18]. Therefore, we asked whether
roX RNAs might exhibit the same behavior, indicative of
a requirement for complex assembly for their integrity.
We expressed roX1 RNA constitutively from an H83roX1
transgene and determined whether roX1 RNA could
accumulate and perhaps even associate with the X chro-
mosomes in females, which lack MSL complexes. We
found that ectopic roX1 RNA failed to bind the X chro-
mosome in females as assayed by in situ hybridization
(Figure 3d,g). The Hsp83 promoter was active in females,
as RNA expressed from H83roX1 was detected as a single
band of hybridization at the transgene insertion site on an
autosome (Figure 3g, arrowhead). Examination of whole
mounts showed that the RNA did not accumulate any-
where within the female nuclei except at its site of syn-
thesis (Figure 3d, arrowhead). Our in situ hybridizations
may not have detected female RNA that was more dis-
persed throughout the cell, so we performed Northern
analysis, which indicated that the roX1 RNA synthesized
by the transgene was stable in males but failed to accu-
mulate to high levels in females (Figure 3e, lane 5). To
determine whether the roX1 RNA produced from the
H83roX1 transgene could be stabilized by the presence of
the MSL complex, we assayed its behavior in males
lacking endogenous roX1, or females that form MSL
complexes as a result of ectopic expression of Msl2 [19].
We found that transgenic roX1 RNA associated with the
X chromosome in males and in Msl2-expressing females
(Figure 3c,f,h). Thus, roX1 RNA is dependent on the
MSL complex for its stability.
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Figure 3
The roX RNAs are unstable in females.
(a–d) Whole-mount in situ hybridization for
roX1 RNA showing nuclei from (a) a wild-type
male, (b) a roX1MB710 mutant male,
(c) a roX1MB710 mutant male carrying an
autosomal H83roX1 transgene, and
(d) a roX1MB710 mutant female carrying the
same H83roX1 transgene. X chromosome
accumulation and sites of transgene
transcription are indicated by arrows and
arrowheads, respectively. (e) Northern blot
probed for roX1 RNA, and rp49 RNA as a
loading control. Lane 1, wild-type male; lane 2,
wild-type female; lane 3, roX1MB710 male; lanes
4 and 5, roX1MB710 male (lane 4) and female
(lane 5) expressing H83roX1. The upper band
in roX1MB710 males is thought to be incorrectly
processed RNA derived from the insertional
mutation. (f–h) In situ hybridizations of polytene
chromosome spreads probed for roX1 RNA in
(f) a roX1ex6 mutant male carrying an autosomal
H83roX1 transgene inserted at 61B,
(g) a roX1ex6 mutant female carrying the same
H83roX1 transgene with a hybridization signal
only at 61B, and (h) a female of genotype y w
roX1ex6; [H83roX1]/[H83M2-6I] ectopically
expressing both roX1 RNA and complete MSL
complexes. (i) Wild-type female expressing an
H70roX2 transgene following heat-shock
induction, probed for roX2 transcripts. In (f–i),
the X chromosome is labeled and an
arrowhead indicates the site of transcription
from the autosomal transgene.
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We also ectopically expressed the roX2 RNA in females,
under control of the heat shock inducible Hsp70 pro-
moter. Similar to the results from roX1 transgenic
females, when roX2 RNA was ectopically expressed in
females, only the site of nascent RNA production was
evident (Figure 3i, arrowhead). As the transgenic RNA
was indistinguishable from endogenous roX2 RNA and
we lack a roX2 mutant, we could not determine whether
the RNA expressed in females from the H70roX2 trans-
gene would be stabilized and associate with the X chro-
mosome if the MSL complex were provided. The lack of
X chromosome staining after induction of the Hsp70 pro-
moter by heat shock was, however, consistent with our
transgenic roX1 results, suggesting that the MSL proteins
play a positive role in roX RNA stabilization, possibly
through direct physical interaction.
The roX1 cDNA used in our analysis lacked approxi-
mately 300 nucleotides of 5′ transcribed roX1 sequence
(data not shown), and yet produced RNA that could bind
the X chromosome like wild-type roX1 RNA. Therefore,
we further subdivided roX1 to determine whether the
ability to bind the X chromosome was confined to the 5′
one-third, or 3′ two-thirds of the RNA. The truncated
RNAs were produced using subfragments of the full-
length sequence under the control of the Hsp83 promoter
(H83–5′roX1 and H83–3′roX1). We found that neither the
5′ nor the 3′ RNA was stable, even in males (Figure 4a,b).
Transgenic animals carrying both constructs were
obtained by genetic crosses, but the separate pieces of
RNA were unable to reassemble into stable complexes on
the X chromosome (Figure 4c,d). We conclude that roX
synthesis, assembly and stability are likely to be tightly
coupled. Without proper assembly, segments of roX RNA
are targets for efficient destruction.
Ordered assembly of roX RNAs 
The idea that the MSL complex assembles at chromatin
entry sites rests on the observation that these are the only
places partial MSL complexes bind when one subunit is
removed by mutation. Therefore, we determined
whether roX RNAs might also be associated with these
partial complexes in the absence of spreading into flank-
ing chromatin. To visualize chromatin entry sites, we
used females that ectopically express Msl2 but are
mutant for msl3 or mle. They assemble partial MSL com-
plexes at the same sites as dying mutant males, but are
viable and produce excellent polytene chromosomes
(Figure 5a,b,e,f). Surprisingly, we found a difference in
the localization of roX1 and roX2 RNAs in msl3 mutants.
Although roX1 RNA was detected only at cytological
position 3F, the site of its synthesis, roX2 was consis-
tently seen at many chromatin entry sites including 3F
(Figure 5c,d). This result suggests that roX2 may assem-
ble first into partial MSL complexes and then be
exported to other chromatin entry sites. These roX2-con-
taining complexes may subsequently acquire a second
roX RNA species (such as roX1) or be present in distinct
complexes from roX1. 
When we examined mle mutants for localization of roX
RNAs, we found that roX2 RNA was no longer able to
move to other chromatin entry sites, but was only detected
at its site of synthesis, like roX1 (Figure 5g,h). This
demonstrates that the Mle helicase plays an early role,
perhaps in packaging roX2 RNA into growing MSL com-
plexes. Blocking assembly at this point prevents roX2 RNA
from reaching other chromatin entry sites.
To further test the idea that roX2 assembly may occur at an
earlier step than roX1, we determined whether roX2 RNA
assembled correctly in the absence of roX1. We found that
roX2 RNA is localized to the male X chromosome in the
absence of roX1, with no apparent perturbation of its stain-
ing pattern (data not shown). We conclude that roX2 RNA,
like the MSL protein complex [11], is independent of roX1
for localization on the X chromosome.
Figure 4
Truncated roX RNAs are unstable in both sexes. (a–c) Whole-mount
in situ hybridization for roX1 RNA showing roX1ex6 mutant males
expressing (a) H83–5′roX1, (b) H83–3′roX1 and (c) both transgenes
in the same individual. Arrowheads indicate sites of transcription of the
transgenes. Sites of transcription for the H83–5′roX1 construct are
not consistently detected, suggesting that the truncated RNA made by
this transgene may be particularly unstable or too short
(900 nucleotides) to be reliably detected. (d) In situ hybridization to
spread polytene chromosomes from a strain expressing both 5′ and 3′
transgenes, showing two sites of transcription (arrowheads) but failure
to accumulate roX1 RNA on the X chromosome.
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The roX2 RNA coimmunoprecipitates with MSL complexes
MSL complexes can be immunoprecipitated from Schnei-
der SL2 tissue-culture cells, which exhibit male-like X
chromosomal MSL complex and histone H4Ac16 by
immunostaining [20]. Therefore, we performed reverse
transcription (RT)–PCR analyses to determine whether
roX RNA could be coprecipitated with MSL complexes
from SL2 cell extracts. We focused on roX2 because our
genetic experiments predicted that it may be included at
an early step in MSL complex assembly. RT–PCR prod-
ucts were first confirmed from male larval total RNA, SL2
cell total RNA, and SL2 cell protein lysates (Figure 6A),
using primers flanking an intron of 141 bp [10]. Surpris-
ingly, a smaller RNA with a 270 bp intron removed was
the predominant product detected in both male larvae and
SL2 cell total RNA. The intron encompasses the 141 bp
intron and utilizes the same 3′ splice site (Figure 6b). The
spliced roX2 RNA was detected in immunoprecipitates
from SL2 cells using anti-Msl1 and anti-Mle antibodies
(Figure 6a, lanes 5,7), but not with pre-immune sera or in
the absence of antibodies (Figure 6a, lanes 6,8,9). We con-
clude that the MSL proteins are physically associated with
the spliced form of roX2 RNA
Discussion
Until recently, it had been assumed that X-chromosome-
specific cis-acting sequences would be associated with
most genes bound by the MSL proteins. However, studies
of roX1 suggested that, if provided with a chromatin entry
site (a roX1 transgene), the MSL complex could be
attracted in cis to genes on autosomes that were never
before dosage-compensated. The complex could not nor-
mally gain access to the autosomes in wild-type males
because the MSL chromatin entry sites are found only on
the X chromosome. Here, we have shown that a roX2
transgene can also function as a chromatin entry site for
spreading of MSL complexes into autosomal chromatin,
fulfilling a key prediction of our model for X chromosome
recognition by the MSL complex.
In addition to roX genes functioning as chromatin entry
sites, it is thought that the RNAs themselves may play
roles in MSL complex assembly or function on the X chro-
mosome. Although large ribonucleoprotein machines are
well known in the form of ribosomes, spliceosomes and
telomerases, RNAs have not been considered important
factors in transcriptional regulation. There have been
recent reports, however, of transcriptional control by non-
coding RNAs in several diverse systems [21,22]. A promi-
nent example is the Xist RNA, which has been shown to
play a central role in silencing most of the genes along one
of the two X chromosomes in mammals [23–26]. Another
example is SRA, a novel non-coding RNA discovered as a
coactivator of steroid hormone receptors [27]. Individually,
roX RNAs do not appear essential for MSL complex
assembly on the X chromosome, but the phenotype of
mutant embryos that lack roX1, roX2 and an unknown
number of neighboring genes suggests that assembly of
the MSL complex is delayed or abolished when both
RNAs are removed [12].
Our data are consistent with assembly of roX RNAs into
MSL complexes. First, roX2 RNA can be immunoprecipi-
tated from male tissue-culture cells, using anti-Msl1 or
140 Current Biology Vol 10 No 3
Figure 5
Localization of roX RNAs in msl3 and mle
mutants. (a–d) Locations of molecules on the
X chromosome of msl32 mutants. (a) Hoechst
and (b) anti-Msl1 antibody staining pattern on
the central region of the X chromosome
showing the location of the chromatin entry
sites with the roX2 locus at 10C particularly
strongly stained. (c) In situ hybridization
showing roX1 RNA (green) only at its site of
synthesis (arrowhead at 3F). (d) The same
nucleus with roX2 RNA (red) at many
chromatin entry sites, including 3F and its own
site of synthesis at 10C (arrowhead).
(e–h) Locations of molecules in an mle1
mutant. (e) Hoechst and (f) anti-Msl1 antibody
staining pattern showing that 10C binds partial
MSL complexes only weakly. (g) In situ
hybridization showing roX1 RNA (green) only
at its site of synthesis (arrowhead at 3F). (h) In
situ hybridization showing roX2 RNA (red) only
at its site of synthesis (arrowhead at 10C). 
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anti-Mle antibodies. Second, we have shown that the roX
RNAs are highly unstable in the absence of MSL proteins
even if their synthesis is driven by a strong constitutive or
inducible promoter. Third, movement of roX2 RNA from
its site of synthesis to other chromatin entry sites requires
Mle helicase. These observations are most easily under-
stood if the MSL proteins physically contact the roX
RNAs, protecting them from cytoplasmic export or degra-
dation and targeting them instead to the X chromosome.
One clear difference between roX1 and roX2 RNAs is that
roX2 RNA can travel to ~35 other chromatin entry sites
along the X chromosome in the absence of Msl3. Matura-
tion of the complex is thought to take place at these sites
and then to initiate spreading into flanking chromatin. In
the same nuclei lacking Msl3 protein, roX1 RNA is found
only at its site of transcription. This suggests that the
protein and RNA components of the MSL complex may
assemble in a stepwise manner at several sites, and that
roX2 may play a role in early events (Figure 7).
In previous work, we compared the binding sites for
partial MSL complexes that lacked either the Msl3
protein or the Mle helicase [14]. The two different kinds
of incomplete complexes bound nearly identical sets of
chromatin entry sites in msl3 and mle mutants. A notable
exception, however, was the 10C chromatin entry site,
now known to be the roX2 gene. Partial MSL complexes
lacking Msl3 bound 10C very well, but partial complexes
lacking the Mle helicase did not. With improved staining
methods, we can now sometimes detect faint MSL com-
plexes at 10C in mle mutants (Figure 5f). Nevertheless,
while the site at 10C is among the strongest in msl3
mutants (Figure 5b), it is one of the weakest sites in mle
mutants (Figure 5f). Thus, assembly of MSL proteins at
roX2 may be particularly dependent on the Mle helicase.
The placement of Mle early in the pathway to MSL
complex assembly is consistent with the results of Gu
et al. [16] based on studies of X chromosome association
of the Mof acetyltransferase. Perhaps the first MSL sub-
units assemble with nascent roX2 RNA in a process
requiring the Mle helicase to fold the RNA correctly
(Figure 7). Only after maturation is completed by the
addition of more MSL proteins, perhaps other RNAs, and
the activation of the Mof histone acetyltransferase [16], is
the MSL complex able to locate and act on its many
target genes along the male X chromosome.
Conclusions
Our results support three interrelated roles for roX genes
in dosage compensation: first, to produce RNA compo-
nents of the MSL complex; second, to provide sites for
complex assembly and, third, to mark the X chromosome
for dosage compensation by acting as nucleation sites for
spreading the MSL complex in cis to surrounding genes.
We have presented a model for an ordered pathway of
MSL–roX assembly, in which roX2 RNA joins partial
MSL complexes at an early step and is exported to other
chromatin entry sites in a process dependent on the Mle
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Figure 6
Association of the MSL complex with roX2 RNA. (a) Southern blot of
RT–PCR products. Lane 1, the unspliced product from the roX2
78.13 cDNA [10]; lane 2, male larval total RNA (5 µg); lane 3, SL2 cell
total RNA (5 µg); lane 4, SL2 cell protein lysate (100 µg); lane 5, Msl1
immunoprecipitate; lane 6, immunoprecipitation using Msl1
pre-immune serum; lane 7, Mle immunoprecipitate; lane 8,
immuno-precipitation using Mle pre-immune serum; lane 9,
immunoprecipitation with no antibody. Samples in lanes 1–4 were
generated with 30 cycles of PCR and subsequently diluted
100–1000-fold. Samples in lanes 5–9 were generated with 20 cycles
of PCR. All samples were run on the same gel but lanes 1–4 were
exposed for 2 h and lanes 5–9 for 11 h. (b) The intron size and the
location of roX2 primers (arrows). This intron sequence was confirmed
by direct sequencing of the spliced product from male larvae.
Figure 7
Model of MSL complex assembly. (a) The Msl1 and Msl2 proteins
appear to form the core of the dosage compensation complex which
binds the chromatin entry sites, two of which are roX1 and roX2.
(b) The Mle helicase is required to transport roX2 RNA to other
chromatin entry sites in partial MSL complexes. (c) Partial complexes
acquire Msl3, Mof histone acetyltransferase, roX1 RNA and possibly
other components. For simplicity, maturation is shown occurring at
roX1, but parallel assembly may happen at other chromatin entry sites.
(d) Mature complex can travel to other chromatin entry sites where it
spreads in cis to locate the hundreds of ordinary genes which must be
hypertranscribed in males.
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helicase. The roX2-containing complexes may complete
assembly at other chromatin entry sites, perhaps by
acquiring a second roX RNA species (such as roX1). Only
mature complexes are functional to spread and dosage
compensate flanking genes on the X chromosome.
Materials and methods
Drosophila stocks and germline transformation
Larvae and flies were raised on standard cornmeal-yeast-agar-molasses
medium containing propionic acid. P-element constructs were microin-
jected into y w; P[∆2–3] Ki/+ embryos that contain a stable source of P
transposase [28]. The roX1MB710 mutation and the roX1ex6 deletion
were reported in Meller et al. [11]. All mutants not specifically mentioned
are described in Flybase (http://flybase.bio.indiana.edu/).
Transgene construction
The genomic roX2 transgene contained a 4 kb NotI fragment inserted
into pCaSpeR 3. The transgenes expressing roX1 under control of
the Hsp83 promoter each contained an EcoRI fragment from a roX1
cDNA  [11], inserted in the ‘sense’ direction into the EcoRI site of
pCaSpeR-hs83T3. Plasmid pCaSpeR-hs83T3 is a modified version of
pCaSpeR HS83 [29] carrying a tra2 polyadenylation signal (a 450 bp
PstI fragment) inserted into the PstI site of the vector. H83roX1 contained
a 3.3 kb EcoRI fragment from cDNA roX1-c20 inserted into pCaSpeR-
h83T3. H83–5′roX1 contained a 908 bp EcoRI fragment (bp 235–1143
of cDNA roX1-c3, numbering from Meller et al. [11]), while H83–3′roX1
contained a 2.5 kb EcoRI fragment of roX1-c3 (bp 1143–3695) inserted
into pCaSpeR-h83T3. A complete roX1-c3 cDNA, like roX1-c20, was
capable of producing roX1 RNA that bound the X chromosome in trans
(data not shown). The roX1 transgenes were assayed for the ability to
produce roX1 RNA that bound the X chromosome in both roX1MB710 and
roX1ex6 mutants, with identical results. The H70roX2 transgene, express-
ing cDNA roX2-78.13 [10] under the control of the Hsp70 promoter,
contained a BamHI–StyI fragment (1212 bp) ligated into the BglII and
XbaI sites of vector pCaSpeR-hs [30].
Polytene chromosome immunostaining
Immunofluorescence using anti-MSL antibodies to stain polytene
chromosomes was as described previously [9].
In situ hybridizations
Whole-mount RNA in situ hybridizations were performed as described in
Meller et al. [11]. In situ hybridization of polytene chromosome spreads
was as follows. Larvae were grown at 18°C in uncrowded vials on stan-
dard cornmeal molasses food. Larvae were dissected in PBS, 4%
formaldehyde, 1% Triton-X100, and fixed 45 sec. The fixative was
replaced with 50% acetic acid, 4% formaldehyde for 2 min and then the
glands were placed in lactoacetic acid (lactic acid: water: acetic acid;
1:2:3) and spread under a siliconized coverslip. The slides were frozen in
liquid nitrogen, the coverslips removed and the tissue dehydrated in
ethanol for 30 min, air dried, rehydrated in 70% and 30% ethanol, and
finally in PBT (PBS containing 0.1% Tween 20). The tissue was fixed
again in 4% formaldehyde in PBT for 15 min, washed 3 × 5 min in PBT
and then treated with proteinase K (20 µg/ml in PBT) for 5.5 min. Follow-
ing two 2 min washes in glycine (2 mg/ml) and two washes in PBT, the
slides were fixed in 4% formaldehyde for 10 min. After two 5 min PBT
washes, the slides were prehybridized 3 h at 42°C in 50% formamide, 5×
SSC, 5× Denhardt's solution, 500 µg/ml salmon sperm DNA, 250 µg/ml
tRNA. The slides were treated with the same hybridization solution
(6–10 µl) containing single-stranded antisense riboprobes (30–50 ng)
labeled with either digoxygenin or biotin (Boehringer Mannheim). Follow-
ing overnight hybridization at 42°C in a humid chamber, the slides were
washed sequentially, for 20 min each, in 50% formamide, 5× SSC,
10 mM DTT (42°C), 2× SSC (42°C), 0.1× SSC (23°C), 1× PBT (23°C),
and then blocked for 30 min in PBT containing 5 mg/ml BSA. In cases
where both biotin and digoxygenin probes were used, the slides were
treated with fluorescein-labeled avidin (Oncor) for 1 h at 37°C then
washed in PBT 3 × 3 min. The slides were treated with anti-digoxygenin
monoclonal antibody (Sigma) and biotinylated anti-avidin antibody (1:200,
Oncor) for 1 h at 37°C, washed 3 × 3 min in PBT, and then treated with
1:200 digoxygenin-labeled anti-mouse F(ab')2 fragments (Boehringer
Mannheim) at 37°C for 1 h followed by washes in PBT. The probes were
visualized by treating with rhodamine-labeled anti-digoxygenin Fab frag-
ments (1:200, Boehringer Mannheim) and fluorescein-labeled avidin at
4°C overnight. Following washes, the DNA was counterstained with
1 µg/ml DAPI and photographed under epifluorescence.
Double labeling for colocalization of roX RNAs and MSL protein
Chromosomes were spread, dehydrated and dried as above. The slides
were hybridized with biotin-labeled riboprobes (1 µg/ml) in ChromaHyb
600 hybridization buffer (Quantum) at 60°C overnight. The slides were
washed at 60°C in ChromaHyb wash (Quantum) diluted 1:80 for 3 min,
1:200 for 2 min, 1:80 for 30 sec, 1:400 three times for 30 sec each.
The final wash was in PBT for 10 min at 23°C. The slides were blocked
in PBT + 0.5% BSA 30 min at 23°C. The slides were treated in a humid
chamber overnight at 4°C with affinity purified rabbit anti-Msl1 antibody
(1:50) and fluorescein-labeled avidin (1:200), and washed 3 × 3 min in
PBT. The slides were treated with biotinylated anti-avidin antibody for
1 h at 37°C, and washed 3 × 3 min in PBT. The RNA signal was
detected with fluorescein-labeled avidin, and the MSL signal was visual-
ized with Texas-Red-labeled goat anti-rabbit antibodies. 
Northern blot analysis
Northerns were performed as described previously [31] using 5 µg
polyA+ adult RNA per lane and random-primed double-stranded roX1
cDNA20 as probe.
Immunoprecipitation and RT–PCR
Total RNA of male larvae and SL2 cells were isolated using TRIzol
reagent (Life Technologies). The total protein lysates of SL2 cells were
prepared by vortexing SL2 cells in extraction buffer [27]. Lysate contain-
ing 100 µg total protein was incubated with 3 µl rabbit polyclonal anti-
body or preimmunune sera for 35 min at 4°C followed by a 30 min
incubation at 4°C with protein A–Sepharose pre-equilibrated with extract
buffer. Beads were washed three times with five volumes of extract buffer
and incubated for 20 min at 37°C with RNase-free DNaseI (Boehringer
Mannheim). RNA was isolated by phenol-chloroform extraction and
ethanol precipitation. First-strand cDNA was synthesized using Super-
ScriptII reverse transcriptase (Life Technologies). Ten percent (2 µl) of
the reaction was used in a 50 µl PCR amplification by using 0.2 µM of
rox2-specific primers (2–1: 5′-TTGGCATTTT GCTCTTGTTTTTCTC-3′
and 2–2: 5′-CGTTACTCTTGCTTGATTTTGCTTCG-3′; see Figure 6).
PCR was performed as follows: 4 min at 94°C, 20 or 30 cycles of 1 min
at 94°C, 1 min at 60°C, 1 min at 72°C, and 10 min at 72°C. RT-PCR
products were electrophoresed, blotted and hybridized with a probe cor-
responding to the sequenced roX2 PCR product from male larvae.
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